NZ239146A - A recombinant marek's disease virus serotype 1 (mdv-1) vaccine - Google Patents

A recombinant marek's disease virus serotype 1 (mdv-1) vaccine

Info

Publication number
NZ239146A
NZ239146A NZ239146A NZ23914691A NZ239146A NZ 239146 A NZ239146 A NZ 239146A NZ 239146 A NZ239146 A NZ 239146A NZ 23914691 A NZ23914691 A NZ 23914691A NZ 239146 A NZ239146 A NZ 239146A
Authority
NZ
New Zealand
Prior art keywords
mdv
dna
foreign gene
bamhi
plasmid
Prior art date
Application number
NZ239146A
Other languages
English (en)
Inventor
Robin Wilson Morgan
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of NZ239146A publication Critical patent/NZ239146A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ239146A 1990-07-30 1991-07-26 A recombinant marek's disease virus serotype 1 (mdv-1) vaccine NZ239146A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55973590A 1990-07-30 1990-07-30

Publications (1)

Publication Number Publication Date
NZ239146A true NZ239146A (en) 1992-12-23

Family

ID=24234797

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ239146A NZ239146A (en) 1990-07-30 1991-07-26 A recombinant marek's disease virus serotype 1 (mdv-1) vaccine

Country Status (11)

Country Link
EP (1) EP0473210B1 (ja)
JP (1) JP3159476B2 (ja)
KR (1) KR0153005B1 (ja)
CN (1) CN1056879C (ja)
AU (1) AU645333B2 (ja)
CA (1) CA2047290C (ja)
DE (1) DE69101683T2 (ja)
ES (1) ES2056565T3 (ja)
HU (1) HU219377B (ja)
NZ (1) NZ239146A (ja)
ZA (1) ZA915563B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
EP0750670A1 (en) * 1994-02-07 1997-01-02 Cornell Research Foundation, Inc. Compositions useful in controlling marek's disease
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
CA2216139C (en) * 1995-03-23 2013-01-08 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
NZ309172A (en) * 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus
FR2767335B1 (fr) * 1997-08-14 2001-09-28 Ct Nat D Etudes Veterinaires E Adenovirus aviaire celo recombinant comme vecteur vaccinant
ES2360225T3 (es) 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
WO2004018683A1 (en) 2002-08-12 2004-03-04 Akzo Nobel N.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
CN100334217C (zh) * 2005-08-15 2007-08-29 北京市农林科学院 重组鸡马立克氏病病毒转移载体及应用
EP2412382A1 (en) 2010-07-29 2012-02-01 University Court of the University of Edinburgh Recombinant Trypanosoma theileri parasite
US9139824B2 (en) 2011-04-21 2015-09-22 The University Court Of The University Of Aberdeen Sapolegina protein in for use as a medicament
ES2717441T3 (es) 2012-10-09 2019-06-21 Univ Gent Vacuna contra Cooperia
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) * 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
CN118703704A (zh) * 2024-07-22 2024-09-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种用于鉴别表达ibdv vp2基因的重组mdv疫苗株的引物、试剂盒、方法及其应用
CN119842636A (zh) * 2025-03-18 2025-04-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 表达血清4型禽腺病毒Fiber2基因的重组马立克氏病病毒及其构建方法和应用
CN119842637A (zh) * 2025-03-18 2025-04-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 表达IBDV VP2和FAdV-4 Fiber2基因的重组马立克氏病病毒及其构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
EP0431668B1 (en) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
US6087127A (en) * 1990-08-24 2000-07-11 Board Of Trustees Operating Michigan State University Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Also Published As

Publication number Publication date
KR920002782A (ko) 1992-02-28
ZA915563B (en) 1992-07-29
CN1060680A (zh) 1992-04-29
JPH06233682A (ja) 1994-08-23
DE69101683T2 (de) 1994-07-21
HU219377B (en) 2001-03-28
AU8143791A (en) 1992-02-06
EP0473210A2 (en) 1992-03-04
DE69101683D1 (de) 1994-05-19
ES2056565T3 (es) 1994-10-01
CA2047290C (en) 2002-12-10
KR0153005B1 (ko) 1998-10-15
JP3159476B2 (ja) 2001-04-23
HUT58371A (en) 1992-02-28
CN1056879C (zh) 2000-09-27
EP0473210A3 (en) 1992-06-10
HU912526D0 (en) 1992-01-28
AU645333B2 (en) 1994-01-13
EP0473210B1 (en) 1994-04-13
CA2047290A1 (en) 1992-01-31

Similar Documents

Publication Publication Date Title
EP0473210B1 (en) Recombinant Marek's disease virus
CA2031164C (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
JP3756950B2 (ja) 組換え型シチメンチョウヘルペスウイルス、及びその使用
AU708077B2 (en) Live recombinant avian vaccine using an avian herpesvirus as vector
US5853733A (en) Recombinant herpesvirus of turkeys and uses thereof
Sondermeijer et al. Avian herpesvirus as a live viral vector for the expression of heterologous antigens
US5733554A (en) Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease
JPH08500969A (ja) 七面鳥の組換えヘルペスウイルス及びそれらの使用
US6913751B2 (en) Recombinant avian herpesvirus useful in vaccine production
US5231023A (en) Recombinant Marek's disease virus
EP1467753A2 (en) Recombinant herpesvirus of turkeys and use thereof
DE69227860T2 (de) Rekombinante Geflügelpockenvazzine zum Schutz gegen die Marek-Krankheit
US20100008948A1 (en) Recombinant herpesvirus useful in vaccine production
JP3284118B2 (ja) 連続的鳥類細胞株を用いるマレック病ウイルスの製造方法
US5279965A (en) Recombinant infectious laryngotracheitis virus
JPH10501964A (ja) 試験管内でｇＤ遺伝子を発現するように形質転換されたヘルペスウィルス
CA2373454A1 (en) Recombinant infectious laryngotracheitis virus vaccine
US20050019348A1 (en) Marek's disease virus vaccine
JPH06141853A (ja) 組換え鶏伝染性喉頭気管炎ウイルス及びその製法
CN120574868A (zh) 用于预防鸡法氏囊、新城疫和禽流感的多价疫苗及其制备方法

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired